Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05063344 · ClinicalTrials.gov registry record
NOWDx Test for the Diagnosis of Syphilis
A clinical trial of Syphilis Infection and Treponema Pallidum Infection, sponsored by NOWDiagnostics.
- Completed
- Registry status
- 1,535
- Enrollment target
- 6
- Study locations
NCT05063344 is a study of Syphilis Infection and Treponema Pallidum Infection that has completed, run by NOWDiagnostics. The registered enrollment target is 1,535 participants. The trial reports 6 study locations across 6 states.
The verdict
NCT05063344, a study of Syphilis Infection and Treponema Pallidum Infection, has completed, sponsored by NOWDiagnostics.
- COMPLETED
- Registry status
- 1,535 participants
- Enrollment target
- 6
- Study locations
Study Summary
This study is designed to compare the performance of the NOWDx Syphilis Test to a currently marketed device. The intent is to show the rapid test device is comparable to the currently marketed device. The NOWDx Syphilis Test is intended for qualitatively detecting the presence or absence of human antibodies to syphilis in human whole blood to aid in the diagnosis of infection caused by Treponema pallidum.
Conditions Studied
Interventions
- DEVICE Diagnostic Test: NOWDx Syphilis Test
Study Locations (6)
Arizona
- AMR Tempe - Tempe
California
- Matrix Clinical Research - Los Angeles
Florida
- Segal Trials - North Miami
Nevada
- AMR Las Vegas - Las Vegas
New Jersey
- People Care Institute - West Orange
Washington
- Multicare Rockwood - Cheney
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,535 participants |
| Start Date | 2021-10-04 |
| Est. Completion | 2023-12-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05063344
The ClinicalTrials.gov registry entry for NCT05063344 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,535 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NOWDiagnostics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Syphilis Infection appearing as the primary indexed condition, and to 1 intervention - of which Diagnostic Test: NOWDx Syphilis Test is the first listed.
NCT05063344 reports 6 study locations spanning 6 distinct geographic areas - top geographies include Arizona, California, Florida.
Frequently Asked Questions
What is clinical trial NCT05063344 about?
NCT05063344 is a clinical study titled "NOWDx Test for the Diagnosis of Syphilis". This study is designed to compare the performance of the NOWDx Syphilis Test to a currently marketed device. The intent is to show the rapid test device is comparable to the currently marketed device. The NOWDx Syphilis Test is intended for qualitatively detecting the presence or absence of human an...
What is the current status of trial NCT05063344?
This trial is currently completed. The enrollment target is 1,535 participants. The study started on 2021-10-04. Estimated completion is 2023-12-11.
What conditions does trial NCT05063344 study?
This clinical trial studies the following conditions: Syphilis Infection, Treponema Pallidum Infection.
What interventions are being tested in trial NCT05063344?
The interventions under investigation include: Diagnostic Test: NOWDx Syphilis Test (DEVICE).
Who is sponsoring clinical trial NCT05063344?
This trial is sponsored by NOWDiagnostics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05063344 being conducted?
This trial has 6 study locations across Arizona, California, Florida, Nevada, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Syphilis Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasma. Samples From At-risk, HIV-positive, Pregnant, and Healthy Individuals Will Assess Assay Performance Versus Established Comparator Tests.
RECRUITING
-
LIMIT Trial - Lidocaine With Intramuscular Injection of Benzathine Penicillin G for Treponema Pallidum Treatment
RECRUITING · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.